Company Number: 12481593

Analysis Date: 2025-07-20 17:26 UTC

1. Risk Rating: MEDIUM
   The company shows a recent improvement in net current assets and shareholders’ funds compared to prior years, indicating some recovery. However, the very low absolute asset base (£13 total net assets) and negligible fixed assets, combined with prior years’ cumulative losses, suggest ongoing financial fragility.

2. Key Concerns:

• Minimal Capitalization and Asset Base: Share capital is only £10 and net assets are £13, indicating very thin capitalization. This limits financial resilience and may hinder the ability to absorb shocks or invest in growth.
• Historical Negative Equity: The company carried significant negative shareholders’ funds in prior years (-£943k), implying accumulated losses or liabilities exceeding assets until the latest year. This history raises concerns about prior financial distress or undercapitalization.
• No Employees and Limited Scale: The company reported zero employees in the latest accounts, which raises questions about operational capacity and sustainability of the business model as a specialist medical practice.

3. Positive Indicators:

• Current Compliance and Timely Filings: Accounts and confirmation statements are up to date without overdue filings, indicating good regulatory compliance.
• Recent Improvement in Working Capital: The net current assets moved from a large deficit to a small positive (£12), suggesting some improvement in liquidity management or reduction of liabilities.
• Established Directors with Relevant Background: The director is identified as a doctor, consistent with the company’s specialist medical practice SIC code, which supports operational legitimacy.

4. Due Diligence Notes:

• Confirm Nature of Recent Financial Improvement: Investigate the drivers behind the shift from negative to positive net current assets and shareholders’ funds—Was there an injection of capital, debt restructuring, or asset disposal?
• Assess Revenue Streams and Cash Flow: Limited financial detail is available beyond balance sheet snapshots; review P&L data, turnover, and cash flow to evaluate ongoing operational viability and income stability.
• Examine Related Party Transactions or Loans: Given low capital and historical losses, assess whether the company relies on director loans or related party funding to sustain operations.
• Operational Model and Service Delivery: Clarify how the company delivers its specialist medical services without employees and whether it outsources clinical work or contracts with third parties.